Endovenous Versus Liposomal Iron in CKD
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01864161
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01864161
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT01864161. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endovenous Versus Liposomal Iron in CKD
- Condition
- Iron Deficiency Anemia
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- gluconate iron
- Intervention (Drug)
- Liposomal iron
- Lead sponsor
- Federico II University
Record details
- Record id
cardio:ct-nct01864161- Content hash
e974d201ed67dce0b54b64a8a518480b1810374f5e1807f4512fb2a3ca71cc76